BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10461705)

  • 1. Tumor lysis syndrome.
    Ezzone SA
    Semin Oncol Nurs; 1999 Aug; 15(3):202-8. PubMed ID: 10461705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective Prevention and Management of Tumor Lysis Syndrome in Children With Cancer: The Important Contributions of Pediatric Oncology Nurses.
    Li HC; Chung OK; Tam CJ; Chiu SY
    J Pediatr Oncol Nurs; 2015; 32(4):209-18. PubMed ID: 25556106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour lysis syndrome with acute renal failure during imatinib therapy.
    Ali R; Ozkalemkas F; Ozkan A; Ozcelik T; Ozkocaman V; Akdag I; Ozan U; Tunali A
    Leuk Res; 2007 Apr; 31(4):573-4. PubMed ID: 16782190
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
    Otrock ZK; Taher AT; Mahfouz RA; Makarem JA; Shamseddine AI
    Am J Hematol; 2006 Mar; 81(3):220-1. PubMed ID: 16493602
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
    Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
    Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia.
    Al-Kali A; Farooq S; Tfayli A
    J Clin Pharm Ther; 2009 Oct; 34(5):607-10. PubMed ID: 19744017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology, signs, and symptoms of acute tumor lysis syndrome.
    Kaplow R
    Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):6-11. PubMed ID: 12184050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic-phase chronic myeloid leukemia with intracranial hemorrhage complicated with tumor lysis syndrome].
    Oyama C; Arakawa Y; Ikeda Y; Aoki T; Kubota Y; Isobe K; Mori M; Kurihara J; Koh K
    Rinsho Ketsueki; 2021; 62(5):346-351. PubMed ID: 34108312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.
    Hua J; Iwaki Y; Inoue M; Hagihara M
    Int J Hematol; 2013 Aug; 98(2):243-6. PubMed ID: 23649869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any protective effect on organs upon higher uric acid level in tumor lysis syndrome?
    Basturk A; Hacibekiroglu T; Akinci S; Dilek I; Atalay HV
    Ren Fail; 2011; 33(4):465. PubMed ID: 21529279
    [No Abstract]   [Full Text] [Related]  

  • 11. [Painful symmetrical ankle ulcerations. A 73-year old patient with chronic myeloid leukemia].
    Welt K; Ott S; Weiss JM; Scharffetter-Kochanek K
    Hautarzt; 2004 Feb; 55(2):190-3. PubMed ID: 14968332
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of tumor lysis syndrome.
    Doane L
    Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):2-5. PubMed ID: 12184049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving treatment for tumor lysis syndrome: strategies for every oncology nurse.
    ONS News; 2004; 19(9 Suppl):43-4. PubMed ID: 15478582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
    Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
    J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet's disease.
    Karincaoglu Y; Kaya E; Esrefoglu M; Aydogdu I
    Leuk Lymphoma; 2003 Jun; 44(6):1063-5. PubMed ID: 12854911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency. Tumor lysis syndrome.
    Cantril CA; Haylock PJ
    Am J Nurs; 2004 Apr; 104(4):49-52; quiz 52-3. PubMed ID: 15171115
    [No Abstract]   [Full Text] [Related]  

  • 18. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
    Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
    Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of tumor lysis syndrome: prevention and treatment.
    Gobel BH
    Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):12-6. PubMed ID: 12184047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
    Przepiorka D; Gonzales-Chambers R
    Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.